Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Development of therapeutic anti-JAGGED1 antibodies for cancer therapy.

Journal article

Masiero M. et al, (2019), Mol Cancer Ther

FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma.

Journal article

Giatromanolaki A. et al, (2019), Exp Lung Res, 1 - 8

The oncogenic roles of TRPM ion channels in cancer

Journal article

Wong KK. et al, (2019), Journal of Cellular Physiology

Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy.

Journal article

Li D. et al, (2017), Cancer Res, 77, 2699 - 2711

The significance of FOXP1 in diffuse large B-cell lymphoma.

Journal article

Gascoyne DM. and Banham AH., (2017), Leuk Lymphoma, 58, 1037 - 1051

Anti p53/HLA-A*0201 T-cell Receptor Mimic Antibody


BANHAM A. and Li D., (2017)

Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin D.

Journal article

Gascoyne DM. et al, (2017), Endocrinology, 158, 503 - 515

Therapeutic Antibodies against Intracellular Tumor Antigens.

Journal article

Trenevska I. et al, (2017), Front Immunol, 8

Load More